Fontanals-Cirera B,Hasson D, Vardabasso C,Di Micco R, Gantz M, De Pablos A, Morgenstern A,Pamela Wu P, Valle-GarciaD, Darvishian F,Roe J, Davies MA, Vakoc CR, Hernando E and Bernstein E.Harnessing BET inhibitor sensitivity reveals AMIGO2 as amelanoma survival gene. Molecular Cell 2017,68(4):731-744.
Vardabasso C, Gaspar-Maia A, Pünzeler S,Valle-Garcia D, Hasson D, Straub T, Keilhauer EC,Strub T, Dong J, Panda T, Segura M, ChungCY, Yao JL, Singh R, Verma A, Mann M, HernandoE, Hake SB, Bernstein E. Histone variant H2A.Z.2 regulatesproliferation and drug sensitivity of malignant melanoma. Molecular Cell 2015, 59(1):75-88.
Vardabasso C, Hasson D,Chung J, Duarte LF, Ratnakumar K, Bernstein E. Histone variants: linkingchromatin structure to cancer. Review. Cellularand Molecular Life Sciences 2014, May 8.
Kapoor A, Goldberg MS, Cumberland LK, Ratnakumar K, Segura MF, EmanuelPO, Menendez S, Vardabasso C, LeRoyG, Vidal CI, Polsky D, Osman I, Garcia BA, Hernando E, Bernstein E. The histonevariant macroH2A suppresses melanoma progression through regulation of CDK8. Nature 2010, 468: 1105-1109.
Vardabasso C,Manganaro L, Lusic M, Marcello A, Giacca M. The histone chaperone proteinNucleosome Assembly Protein-1 binds HIV-1 Tat and promotes viral transcription.Retrovirology 2008, 5:8.